Retaglutide ni dipeptidyl peptidase-4 (DPP-4) inhibitor yo mu bwoko bwa hypoglycemic imiti ishobora kwirinda iyangirika rya glucagon imeze nka peptide-1 (GLP-1) hamwe na glucose iterwa na insuline irekura polypeptide (GIP) ikoresheje insimburangingo ya insuline mu gihe cyo kwanduza insuline. gusohora glucagon na pancreatic α selile, bityo bikagenzura neza isukari yamaraso nyuma yinyuma. Ikora neza mubijyanye n'ingaruka za hypoglycemic, kwihanganira, no kubahiriza.